Hostname: page-component-78c5997874-lj6df Total loading time: 0 Render date: 2024-11-10T11:18:51.876Z Has data issue: false hasContentIssue false
  • English
  • Français

New users of antipsychotic medication: A population-based cohort study of occupational outcome measures in relation to antipsychotic on-label and off-label prescribing practices

Published online by Cambridge University Press:  23 March 2020

L. Baandrup  and
M. Kruse
L. Baandrup*
Affiliation:
Center for Neuropsychiatric Schizophrenia Research & Center for Clinical Intervention and Neuropsychiatric Schizophrenia Research, Mental Health Center Glostrup, Copenhagen University HospitalGlostrup, DK-2600, Denmark
M. Kruse
Affiliation:
Center for Health Economics Research, University of Southern DenmarkOdense, DK-5230, Denmark
*
*Corresponding author. E-mail address:lone.baandrup@regionh.dk (L. Baandrup).
Get access

Abstract

Background

Treatment with antipsychotic medication is thoroughly investigated in schizophrenia and bipolar disorder but is also widely applied for a diversity of off-label conditions, despite an uncertain risk-benefit ratio. This study examined the relationship between antipsychotic prescribing patterns and labor market affiliation, considering both authority approved and off-label prescriptions and the relation to polypharmacy.

Methods

Register-based cohort study using a dataset of 71,254 new antipsychotic users with a psychiatric diagnosis. Labor market affiliation and duration of welfare payments were analyzed using linear regression models and duration analysis. The analyses were adjusted for the following confounding variables: age, gender, diagnosis, marital status, length of education, and utilization of mental health care services.

Results

The majority of new antipsychotic users received welfare payments for prolonged periods of time during the observation period, even more so for individuals treated with antipsychotic polypharmacy or other antipsychotic combination regimens. The risk of permanently leaving the labor market was also associated with antipsychotic combination regimen.

Conclusions

Antipsychotic treatment, especially in combination with other antipsychotics or other psychotropic drugs, could serve as a marker of subjects with increased need for support to maintain the labor market affiliation. However, causality cannot be inferred from an observational study because of residual confounding that could not be adjusted for in this study.

Keywords

OccupationEmploymentMental illnessAntipsychoticPrescribingPolypharmacy
Type
Original article
Information
European Psychiatry , Volume 31 , January 2016 , pp. 66 - 71
Copyright
Copyright © European Psychiatric Association 2015

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alexander, GC, Gallagher, SA, Mascola, A, Moloney, RM, Stafford, RSIncreasing off-label use of antipsychotic medications in the United States, 1995–2008. Pharmacoepidemiol Drug Saf 2011;20(2):177–184.CrossRefGoogle ScholarPubMed
Domino, ME, Swartz, MSWho are the new users of antipsychotic medications?. Psychiatr Serv 2008;59(5):507–514.CrossRefGoogle ScholarPubMed
Goodwin, GMEvidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2003;17(2):149–173.CrossRefGoogle ScholarPubMed
Herbild, L, Kruse, M Forbruget af antipsykotika. KORA – Det Nationale Institut for Kommuners og Regioners Analyse og Forskning; 2012 Available from http://www.kora.dkGoogle Scholar
http://www.oecdbetterlifeindex.org/countries/denmark [accessed 31.05.15].Google Scholar
Leucht, S, Tardy, M, Komossa, K, Heres, S, Kissling, W, Davis, JMMaintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database Syst Rev 2012;5:CD008016.Google Scholar
Leucht, S, Cipriani, A, Spineli, L, Mavridis, D, Orey, D, Richter, F, et al.Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382(9896):951–962.CrossRefGoogle ScholarPubMed
Maher, AR, Maglione, M, Bagley, S, Suttorp, M, Hu, JH, Ewing, B, et al.Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. J Am Med Assoc 2011;306(12):1359–1369.CrossRefGoogle ScholarPubMed
Marston, L, Nazareth, I, Petersen, I, Walters, K, Osborn, DPJPrescribing of antipsychotics in UK primary care: a cohort study. BMJ Open 2014;4(12):e006135.CrossRefGoogle Scholar
Mors, O, Perto, GP, Mortensen, PBThe Danish Psychiatric Central Research Register. Scand J Public Health 2011;39(7 Suppl.):54–57.CrossRefGoogle ScholarPubMed
Tsang, HW, Leung, AY, Chung, RC, Bell, M, Cheung, WMReview on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust N Z J Psychiatry 2010;44(6):495–504.Google ScholarPubMed
WHO: ICD-10 Classifications of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, version 2007.Google Scholar
WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo; 2008.Google Scholar
Submit a response

Comments

No Comments have been published for this article.